NANTHEALTH INC - NOTE 5.500%12/1

CUSIP: 630104AB3

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Debt / NOTE 5.500%12/1
Market price (% of par)
59.27%
Total 13F principal
$65,160,000
Principal change
+$100,000
Total reported market value
$38,422,000
Number of holders
6
Value change
-$52,318
Number of buys
4
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 630104AB3?
CUSIP 630104AB3 identifies 630104AB3 - NANTHEALTH INC - NOTE 5.500%12/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NANTHEALTH INC - NOTE 5.500%12/1 as of Q4 2018

As of 31 Dec 2018, NANTHEALTH INC - NOTE 5.500%12/1 was held by 6 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $65,160,000 in principal (par value) of the bond. The largest 6 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, ZAZOVE ASSOCIATES LLC, CITADEL ADVISORS LLC, Laurion Capital Management LP, Man Group plc, and Context Capital Management, LLC. This page lists 6 institutional bondholders reporting positions for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.